Bank Of America Corp Pet Vivo Holdings, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.99 - $1.46 $132 - $195	-134 Reduced 11.82%	1,000 $1,000
Q4 2023 Feb 14, 2024	BUY	$0.6 - $2.18 $80 - $292	134 Added 13.4%	1,134 $1,000
Q1 2023 May 12, 2023	SELL	$2.2 - $3.4 $30 - $47	-14 Reduced 1.38%	1,000 $2,000
Q4 2022 Feb 10, 2023	BUY	$1.85 - $2.69 $25 - $37	14 Added 1.4%	1,014 $1,000
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.63 $1,300 - $2,630	1,000 New	1,000 $0

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $5.04M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.